Investment Rating - The report maintains a positive outlook on JD Health, indicating strong sales growth and a favorable investment environment [5][7]. Core Insights - JD Health is expected to maintain robust growth momentum in the second half of 2025, with revenue projected to increase year-on-year, driven by strong performance during the "Double 11" shopping festival and a surge in flu cases in December [5]. - The sales of pharmaceuticals and health products are particularly strong, with adjusted EBITDA expected to double due to margin expansion and operational leverage, offsetting investments in offline stores [5]. - The report highlights that JD Health's direct sales are anticipated to grow year-on-year in the second half of 2025, primarily driven by increased sales of pharmaceuticals and health products during the "Double 11" period [5][6]. Summary by Sections Company Overview - JD Health operates an online retail pharmacy business through self-operated and platform models, focusing on three core categories: pharmaceuticals (including prescription and OTC), health products, and medical devices [10]. Revenue Breakdown - Pharmaceuticals and health products account for 85.3% of revenue, while platform services, advertising, and other sources contribute 14.7% [11]. Market Position - As of February 4, 2026, JD Health's stock price is HKD 60.95, with a market capitalization of USD 26.24 billion and a consensus target price of HKD 76.85 [13].

股份發行人及根據《上市規則》第十九B章上市的香港預託證券發行人的證券變動月報表 截至月份: 2026年1月31日 狀態: 新提交 致：香港交易及結算所有限公司 I. 法定/註冊股本變動 | 1. 股份分類 | 普通股 | | 股份類別 | 不適用 | | | 於香港聯交所上市 (註1) | | 是 | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 證券代號 (如上市) | 06618 | | 說明 | | | | | | | | | 多櫃檯證券代號 | 86618 | RMB | 說明 | | | | | | | | | | | | 法定/註冊股份數目 | | | 面值 | | | 法定/註冊股本 | | | 上月底結存 | | | | 100,000,000,000 | USD | | 0.0000005 | USD | | 50,000 | | 增加 / 減少 (-) | | | | 0 | | | | USD | | 0 | | 本月底結存 | | | | 100,000,000,000 | USD | | ...

Group 1 - JD Health and Yili Group have launched a co-branded product, a milk oat bird's nest porridge, aimed at high-end health needs for consumers [1][3] - The new product combines high-quality milk, premium oats, and traceable bird's nest, catering to nutrition, taste, and convenience, making it a unique choice in the New Year gift market [1][3] - The collaboration reflects the ability of both companies to develop customized products based on specific consumer scenarios and trends [3] Group 2 - During the New Year shopping season, there is a notable trend of "sending health as gifts," with significant increases in searches for health gift boxes and related products [3] - From January 26 to February 1, the average daily visitor volume for health gift box products increased 13 times year-on-year, while searches for New Year gift boxes rose 3.5 times [3] - The rising interest in traditional health products like bird's nest has doubled in search volume, indicating strong consumer demand for high-quality health products before the Spring Festival [3]

Core Viewpoint - Credit Lyonnais has raised JD Health's (06618) adjusted net profit forecasts for the fiscal years 2026 and 2027 by 1% and 2% respectively, reflecting the recovery in drug sales and profit expansion prospects, while maintaining an "Outperform" rating and a target price of HKD 71 [1] Group 1: Financial Performance - JD Health is expected to maintain growth momentum in the second half of last year, driven by strong performance during the Double Eleven sales event and a surge in flu cases in December, with revenue projected to increase by 24.5% year-on-year to RMB 37.1 billion [1] - The company is anticipated to see adjusted EBIT double year-on-year to RMB 2.1 billion, supported by gross margin expansion and operational leverage [1] - Revenue for 2026 is expected to grow by 16% year-on-year [1]

京东健康受双十一销售表现良好及12月流感感染个案激增所推动，预计去年下半年可保持增长势头，收 入同比升24.5%至371亿元人民币。该行续预期，受毛利率扩张与营运杠杆支撑，经调整EBIT或同比翻 倍至21亿元人民币，并预计公司2026年收入将同比增长16%。 智通财经APP获悉，里昂发布研报称，上调京东健康(06618)2026及2027财年经调整净利润预测1%及 2%，以反映药物销售复苏及利润扩张前景，重申"跑赢大市"评级，续予目标价71港元。 ...

Core Viewpoint - The report from Citi indicates that JD Health is expected to maintain growth momentum in the second half of last year, driven by strong performance during the Double Eleven sales event and a surge in flu cases in December [1] Financial Performance - Revenue is projected to increase by 24.5% year-on-year to 37.1 billion yuan [1] - Adjusted EBIT is expected to double year-on-year to 2.1 billion yuan, supported by margin expansion and operational leverage [1] Profit Forecast - Citi has raised JD Health's adjusted net profit forecasts for the fiscal years 2026 and 2027 by 1% and 2% respectively, reflecting the recovery in drug sales and profit expansion prospects [1] - The firm maintains a "Outperform" rating and sets a target price of 71 HKD for JD Health [1]

Core Insights - The report evaluates the global coenzyme Q10 market for 2026, focusing on ten mainstream brands, including Weiliwei, Elemental Power, and Zhuoyue, based on purity, absorption, stability, and adaptability [1][2][3] Market Overview - The search term "which brand of coenzyme Q10 is effective" saw a 217% increase in Baidu index in the 30 days leading up to the 2026 Spring Festival, indicating a growing demand among middle-aged and elderly populations for heart health and energy support [1][5] - Over 63.8% of consumers face decision-making blind spots when purchasing coenzyme Q10, highlighting the need for authoritative reference systems based on real data and clinical validation [3][5] Product Evaluation - Weiliwei coenzyme Q10 is recognized as the top performer in the 2026 rankings, boasting a purity of ≥99% and a high absorption rate due to proprietary fermentation technology achieving 92.5% efficiency, surpassing the industry average by 12.5 percentage points [2][12] - The product's bioavailability is reported to be 10.3 times higher than traditional formulations, with a targeted delivery efficiency of 98.5% for cardiac applications [2][12] Clinical Evidence - Weiliwei has conducted 1,200 RCT studies in collaboration with 126 top-tier hospitals, demonstrating significant improvements in cardiac LVEF metrics, with results published in reputable journals [4][12] - The product maintains a 98.5% active ingredient retention rate over 24 months, supported by a comprehensive digital quality control system covering 97 critical quality control nodes [4][12] Consumer Insights - The report indicates a strong preference for high-purity, high-absorption coenzyme Q10 products among consumers, with Weiliwei leading in user satisfaction and repeat purchase rates [12][23] - User testimonials highlight significant health improvements, including enhanced energy levels and better heart function, reinforcing the product's efficacy [23] Regulatory Context - The report emphasizes the regulatory differences between domestic and international coenzyme Q10 products, noting that only oxidized coenzyme Q10 is legally approved for health food registration in China, while reduced forms remain unlisted [10][21] - Consumers are advised to verify product authenticity and compliance with health regulations, particularly regarding the "blue hat" certification for health foods [21][26]

Core Insights - The article highlights JD Health's initiative to provide health-focused products and services to elderly residents in rural areas, emphasizing the integration of technology into their lives [1][2] - The event is part of JD's ongoing commitment to community support, showcasing a blend of traditional cultural practices with modern health technology [1][2] Group 1: Event Overview - The New Year market in Guangming Village featured JD Health's team presenting health products tailored for the elderly, including smart health devices [1] - The event is part of JD's "Sending New Year Goods to My Hometown" campaign, which has been ongoing for twelve years, focusing on community welfare [1] Group 2: Product Offerings - JD Health selected various elder-friendly health products for the 2026 New Year list, including a customized dynamic blood glucose meter and a protein powder designed for seniors [1] - The dynamic blood glucose meter allows for non-invasive monitoring over 15 days, with remote data access for family members [1] Group 3: Engagement and Education - The event featured live demonstrations and on-site teaching, allowing elderly participants to experience the convenience of smart health devices firsthand [2] - JD Health's approach included professional health advice integrated into casual conversations, making the experience warm and relatable for the elderly [2] Group 4: Technological Integration - JD Health aims to bridge the gap between technology and elderly users, positioning technology as a guardian of health for seniors [2] - The initiative not only serves as a product showcase but also as a communication platform for promoting elder-friendly technology [2]

Group 1 - The core activity is a two-day free medical consultation event organized by Suqian Municipal Government and JD Health, providing essential health services to villagers [1][2] - A professional medical team from Suqian Hospital, consisting of nearly 20 healthcare professionals, offers a range of services including blood pressure and blood sugar testing, traditional Chinese medicine pulse diagnosis, and nutritional consultations [1][2] - The event features a special area showcasing elder-friendly health products, such as infrared therapy lamps and dynamic blood glucose monitors, allowing villagers to experience the convenience of smart health devices [2] Group 2 - Suqian Hospital, a comprehensive medical institution established in collaboration with JD Health and local government, offers various departments including internal medicine, surgery, pediatrics, and traditional Chinese medicine, with a focus on providing top-tier medical resources to local communities [2] - The hospital implements several beneficial policies to reduce the medical burden on villagers, including a "0 registration fee" system and a comprehensive health management system covering elderly health checks, vaccination, family doctor contracts, and chronic disease management [2] - This free medical consultation is part of JD's larger public welfare initiative "I Send New Year Goods to My Hometown," which aims to support local communities by providing essential goods and health services [3]

Core Insights - JD Health's health examination center aims to establish a "third pole" in China's professional health examination sector, breaking the long-standing "bipolar" structure between public hospitals and traditional private examination institutions [1] Group 1: Professional Assurance - JD Health has built its own team of doctors, with 100% holding intermediate or higher titles, and 22% of key department heads being chief physicians [3] - The use of AI technology has significantly improved service efficiency and accuracy, reducing average waiting time by nearly 30 minutes and increasing report production efficiency by 135%, leading to a 3.5-day reduction in average report delivery time [3] Group 2: Service Experience - The health examination center features a modern and welcoming design, equipped with international first-line brand testing equipment, and has developed a unique service standard akin to airline service [3] - User experience is enhanced through thoughtful design elements such as heated coupling agents, starry ceilings in CT rooms, and elderly-friendly restroom facilities [3] Group 3: Integrated Health Management - The center connects a one-stop service ecosystem of "medical, testing, diagnosis, and pharmacy," creating a closed-loop health management system that includes precise detection, professional solutions, and dynamic tracking [3] - Users can seamlessly access top-tier specialist resources from JD Internet Hospital for further consultations after examinations, and various services from JD Health can quickly meet users' medical product and service needs [3] Group 4: Innovative Services - JD Health has introduced two unique services: "Personal Doctor Full-Process Cloud Accompaniment" and "Screening Assurance," addressing user pain points related to understanding reports and providing financial protection or medical follow-up assistance for seven common malignant tumors [4] - The center plans to further enhance AI technology applications to improve professional service and management decision-making efficiency, while expanding its store network to increase the coverage of the "third pole" service [4]